Pathomics Signature for Prognosis and Chemotherapy Benefits in Stage III Colon Cancer

医学 危险系数 比例危险模型 化疗 结直肠癌 阶段(地层学) 肿瘤科 队列 内科学 回顾性队列研究 外科 癌症 置信区间 古生物学 生物
作者
Wei Jiang,Huaiming Wang,Xiaoyu Dong,Xian Yu,Yandong Zhao,Dexin Chen,Botao Yan,Jiaxin Cheng,Shuangmu Zhuo,Hui Wang,Jun Yan
出处
期刊:JAMA Surgery [American Medical Association]
卷期号:159 (5): 519-519 被引量:53
标识
DOI:10.1001/jamasurg.2023.8015
摘要

Importance: The current TNM staging system may not provide adequate information for prognostic purposes and to assess the potential benefits of chemotherapy for patients with stage III colon cancer. Objective: To develop and validate a pathomics signature to estimate prognosis and benefit from chemotherapy using hematoxylin-eosin (H-E)-stained slides. Design, Setting, and Participants: This retrospective prognostic study used data from consecutive patients with histologically confirmed stage III colon cancer at 2 medical centers between January 2012 and December 2015. A total of 114 pathomics features were extracted from digital H-E-stained images from Nanfang Hospital of Southern Medical University, Guangzhou, China, and a pathomics signature was constructed using a least absolute shrinkage and selection operator Cox regression model in the training cohort. The associations of the pathomics signature with disease-free survival (DFS) and overall survival (OS) were evaluated. Patients at the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, formed the validation cohort. Data analysis was conducted from September 2022 to March 2023. Main Outcomes and Measures: The prognostic accuracy of the pathomics signature as well as its association with chemotherapy response were evaluated. Results: This study included 785 patients (mean [SD] age, 62.7 [11.1] years; 437 [55.7%] male). A pathomics signature was constructed based on 4 features. Multivariable analysis revealed that the pathomics signature was an independent factor associated with DFS (hazard ratio [HR], 2.46 [95% CI, 2.89-4.13]; P < .001) and OS (HR, 2.78 [95% CI, 2.34-3.31]; P < .001) in the training cohort. Incorporating the pathomics signature into pathomics nomograms resulted in better performance for the estimation of prognosis than the traditional model in a concordance index comparison in the training cohort (DFS: HR, 0.88 [95% CI, 0.86-0.89] vs HR, 0.73 [95% CI, 0.71-0.75]; P < .001; OS: HR, 0.85 [95% CI, 0.84-0.86] vs HR, 0.74 [95% CI, 0.72-0.76]; P < .001) and validation cohort (DFS: HR, 0.83 [95% CI, 0.82-0.85] vs HR, 0.70 [95% CI, 0.67-0.72]; P < .001; OS: HR, 0.80 [95% CI, 0.78-0.82] vs HR, 0.69 [0.67-0.72]; P < .001). Further analysis revealed that patients with a low pathomics signature were more likely to benefit from chemotherapy (eg, combined cohort: DFS: HR, 0.44 [95% CI, 0.28-0.69]; P = .001; OS: HR, 0.43 [95% CI, 0.29-0.64]; P < .001). Conclusions and Relevance: These findings suggest that a pathomics signature could help identify patients most likely to benefit from chemotherapy in stage III colon cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
shower发布了新的文献求助10
1秒前
Owen的应助被phc采纳,获得10
2秒前
学术智子发布了新的文献求助10
2秒前
旺大财发布了新的文献求助10
2秒前
无极微光的应助被珂珂采纳,获得20
3秒前
5秒前
kakaxi完成签到,获得积分10
6秒前
yangyang完成签到,获得积分10
6秒前
6秒前
Akim的应助被ally采纳,获得10
6秒前
第一作者发布了新的文献求助10
7秒前
8秒前
Cherish完成签到,获得积分10
8秒前
斯文败类的应助被WangJ1018采纳,获得10
9秒前
9秒前
T_T完成签到 ,获得积分10
9秒前
10秒前
同心源完成签到 ,获得积分20
10秒前
daomaihu发布了新的文献求助100
10秒前
10秒前
星辰完成签到,获得积分10
11秒前
11秒前
11秒前
强强的朱呀完成签到,获得积分10
11秒前
ZJJ完成签到,获得积分10
11秒前
欣慰元蝶发布了新的文献求助10
11秒前
wangzhewwe发布了新的文献求助10
12秒前
明亮的新筠完成签到,获得积分20
13秒前
mm完成签到,获得积分10
14秒前
14秒前
Hello的应助被yy采纳,获得10
14秒前
领导范儿的应助被学术智子采纳,获得10
14秒前
Owen的应助被曲凯采纳,获得10
15秒前
Hello的应助被just采纳,获得10
15秒前
15秒前
15秒前
mmmm发布了新的文献求助10
15秒前
Away完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187707
求助须知:如何正确求助?哪些是违规求助? 9575782
关于积分的说明 21843037
捐赠科研通 7785576
什么是DOI,文献DOI怎么找? 3435097
关于科研通互助平台的介绍 2559495
邀请新用户注册赠送积分活动 2481986